Construction of antisense RNA expression vectors and correction of splicing defect in human β-globin gene (IVS-2-654 C→T mutant) in HeLa cells
Tóm tắt
The antisense fragments, which were available inin vitro system, were cloned into the mammalian expression vector pcDNA3, and were transfected into H654 cells, a mammalian cell line stably expressing the thalassaemic (IVS-2-654 C→T) human β-globin gene. In these transfected cells, the level of correctly spliced β-globin mRNA in total β-globin mRNA (β/(β + β*)) was improved from 0.07 (0 d) to 0.22 (3 d), and this effect persisted for up to 15 d post transfection. All the results demonstrated that antisense RNAs were able to be transcribed from the antisense fragment expression vectors stably and effectively suppressed aberrant splicing pattern of the mutated β-globin gene (IVS-2-654 C→T) and restored correct splicing pathway. This work provided a novel approach with potential clinical significance to gene therapy of this kind of splicing mutants including β-thalassaemia (IVS-2-654 C→T) by antisense RNAs.
Tài liệu tham khảo
Huang, S. Z., Zhou, X. D., Zhu, H. et al., Detection of β-thalassemia mutations in the Chinese using amplifies DNA from dried blood specimens,Hum. Genet., 1990, 84: 129.
Huang, S. Z., Ren, Z. R., Zeng, Y. T. et al., Study of the RNA splicing defect in the common Chinese β-thalassemia gene IVS-II nt. 654 C-T by using mRNA/PCR,Science in China (in Chinese), Ser. B, 1991, 21(9):1188.
Gong, L., Sun, Q., Ren, Z. R. et al., Reversal of aberrant splicing of β-thalassemic (IVS-2-654 C-T) pre-mRNA by antisense RNAs,Chinese Science Bulletin, 1997, 42(1): 15.
Sambrook, J., Fritsch, D. F., Maniatis, T.,Molecular Cloning: A Laboratory Manual, New York: Cold Spring Harbor Laboratory, 1989.
Felgner, P. L., Gadek, T. R., Holm, M. et al., Lipofection: A highly efficient lipid-mediated DNA-transfection procedure,Proc. Natl. Acad. Sci. USA, 1987, 84: 7413.
Huang, S. Z., Rodgers, G. R., Zeng, F. Y. et al., Diagnosis of thalassemia using cDNA amplification of circulating erythroid cell mRNA with the polymerase chain reaction,Blood, 1991, 78:2433.
Weatherall, D. J., Clegg, B.,The Thalassemia Syndromes, Oxford: Blackwell Scienfic Publication, 1981.
Huisman, T. J. H., Frequency of common β-thalassemia alleles among different populations: Variability in clinical severity,Brit. J. Haemat., 1990, 75: 454.
Mulligan, R. C., The basic science of gene therapy,Science, 1993, 260: 926.
Cheng, P. W., Receptor ligand-faciliated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin,Hum. Gene Therapy, 1996, 7: 275.
Boshart, M., Weber, F., Jahn, G. et al., A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus,Cell, 1985, 41: 521.
Hock, R. A., Miller, A. D., Osborne, W. R. A., Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines,Blood, 1989, 74(2): 876.
Goodwin, E. C., Rottman, F. M., The 3′-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation,J. Biol. Chem., 1992, 267: 16330.
Voisin, T., Lorinet, A. M., Maoret, J. J. et al., Gi RNA antisense expression demonstrates the exclusive coupling of peptide YY receptors to Gi2 proteins in renal proximal tubule cells,J. Biol. Chem., 1996, 271(1): 574.
Kole, R.,Sickle Cell Disease and Thalassaemias; New Trends in Therapy, Colloque Inserm: John Libbey Eurotext Ldt., 1995, 157–162.